Vaccines, Blood & Biologics
-
EVICEL
STN: BL 125010
Proper Name: Fibrin Sealant (Human)
Tradename: EVICEL
Manufacturer: OMRIX Biopharmaceuticals Ltd, License #1603
Indication: Adjunct to hemostasis in patients undergoing liver surgery, when control of bleeding by conventional surgical techniques is ineffective or impractical
-
Supporting Documents
August 26, 2011 Approval Letter - EVICEL Statistical Review and Evaluation - Evicel January 2, 2008 Approval Letter - Evicel
Use in general surgeryClinical Efficacy Supplement Final Review Memo - Evicel (PDF - 319KB)May 9, 2007 - Evicel
An adjunct to hemostasis for use in patients undergoing liver or vascular surgery when control of bleeding by standard surgical techniques is ineffective or impracticalMarch 21, 2003 - Evicel
Adjunct to hemostasis in patients undergoing liver surgery, when control of bleeding by conventional surgical techniques is ineffective or impracticalSummary Basis for Approval - Evicel (PDF - 38KB)
-
-
Related Information
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.FDA Safety Notification: Risk of Air or Gas Embolism When Using Air- or Gas- Pressurized Spray Devices
July 9, 2010FDA Safety Notification: Risk of Life-Threatening Air or Gas Embolism with the Use of Spray Devices Employing Pressure Regulator to Administer Fibrin Sealants - Evicel
September 22, 2009FDA Approves Sealant to Control Bleeding During Surgery
Press Release: January 16, 2008FDA Approves Expanded Use for Surgical Sealant
Press Release - May 15, 2007
-
-
-







